Before You Invest In G Medical Innovations Holdings Ltd (NASDAQ:GMVD), Consider This Metric

In yesterday’s Wall Street session, G Medical Innovations Holdings Ltd (NASDAQ:GMVD) shares traded at $0.18, unchanged from the previous session.

As of this writing, 1 analysts cover G Medical Innovations Holdings Ltd (NASDAQ:GMVD). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $4.00, we find $4.00. Given the previous closing price of $0.18, this indicates a potential upside of 2122.22 percent. GMVD stock price is now -39.89% away from the 50-day moving average and -89.81% away from the 200-day moving average. The market capitalization of the company currently stands at $2.53M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"


There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $4.00 as their price target over the next twelve months.

In other news, AWM Investment Company, Inc., 10% Owner sold 300,000 shares of the company’s stock on Apr 03. The stock was sold for $218,280 at an average price of $0.73. Upon completion of the transaction, the 10% Owner now directly owns 700,000 shares in the company, valued at $0.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 31, 10% Owner AWM Investment Company, Inc. sold 437,500 shares of the business’s stock. A total of $446,644 was realized by selling the stock at an average price of $1.02. This leaves the insider owning 1,000,000 shares of the company worth $0.18 million. A total of 15.28% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in GMVD stock. A new stake in G Medical Innovations Holdings Ltd shares was purchased by VIRTU FINANCIAL LLC during the first quarter worth $3,000. RENAISSANCE TECHNOLOGIES LLC invested $2,000 in shares of GMVD during the first quarter. In total, there are 11 active investors with 16.92% ownership of the company’s stock.

During the past 12 months, G Medical Innovations Holdings Ltd has had a low of $0.14 and a high of $13.82. The fifty day moving average price for GMVD is $0.2970 and a two-hundred day moving average price translates $1.7536 for the stock.

The latest earnings results from G Medical Innovations Holdings Ltd (NASDAQ: GMVD) was released for Dec, 2022.

G Medical Innovations Holdings Ltd(GMVD) Company Profile

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

Related Posts